1.Department of Urology, West China Hospital, Sichuan University, Chengdu 610041, China
2.Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China
3.Animal Experimental Center, West China Hospital, Sichuan University, Chengdu 610041, China
4.Research Core Facility, West China Hospital, Sichuan University, Chengdu 610041, China
Author bio:
*weiqiang@scu.edu.cn;
wycleflue@scu.edu.cn;
jianzhong.ai@scu.edu.cn
Funds:
the National Key Research and Development Plan(2023YFC3403200);the National Natural Science Foundation of China(82070784;81702536;81974099;82170785);the Science & Technology Department of Sichuan Province, China(2022JDRC0040;21GJHZ0246);the Young Investigator Award of Sichuan University 2017(2017SCU04A17);the Sichuan University-Panzhihua Science and Technology Cooperation Special Fund(2020CDPZH-4);the China Postdoctoral Science Foundation(2021M692306);the Post-Doctor Research Project of West China Hospital of Sichuan University(2021HXBH025)
ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression[J]. MMR, 2024,11(5):643-662.
Cite this article as: Xu H, Li YF, Yi XYL, Zheng XN, Yang Y, Wang Y, et al. ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression. Mil Med Res. 2023;10(1):64.
ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression[J]. MMR, 2024,11(5):643-662. DOI: 10.1186/s40779-023-00500-9.
Cite this article as: Xu H, Li YF, Yi XYL, Zheng XN, Yang Y, Wang Y, et al. ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression. Mil Med Res. 2023;10(1):64. DOI: 10.1186/s40779-023-00500-9.
ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression